Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...
The FDA approved the world’s first adaptive deep brain stimulator for the disease.
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
Hosted on MSN22d
Why Medtronic Just Undercut Its Buy Zone With A 7% DropNeuromodulation uses electrical signals to mask pain. Medtronic points to the strong launch of its spinal cord stimulator, Inceptiv. Brain modulation grew by a mid-20% range in the U.S. Sales of ...
Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results